tiprankstipranks
Trending News
More News >

BCAL Diagnostics Partners with Cancer Care Associates to Boost BREASTEST plus™ Adoption

Story Highlights
  • BCAL Diagnostics partners with Cancer Care Associates to accelerate BREASTEST plus™ adoption.
  • The partnership is a significant milestone, expected to generate revenue and enhance BCAL’s market strategy.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
BCAL Diagnostics Partners with Cancer Care Associates to Boost BREASTEST plus™ Adoption

Don’t Miss TipRanks’ Half-Year Sale

An update from BCAL Diagnostics Limited ( (AU:BDX) ) is now available.

BCAL Diagnostics Limited has announced a strategic partnership with Cancer Care Associates to accelerate the adoption of their non-invasive breast cancer diagnostic test, BREASTEST plus™. This partnership is a significant commercial milestone for BCAL, providing a pathway to market adoption and patient access through a leading oncology network in Australia. The collaboration is expected to generate revenue starting in FY2026 and strengthen BCAL’s commercial rollout strategy, potentially leading to broader national and international partnerships. The integration of BREASTEST plus™ into Cancer Care Associates’ offerings will support uptake in various settings and enhance BCAL’s data collection efforts, aiding discussions around reimbursement and regulatory approvals.

More about BCAL Diagnostics Limited

BCAL Diagnostics is an Australian and US-based biotechnology company focused on advancing early and accurate breast cancer detection. They offer innovative, non-invasive blood tests, such as the BREASTEST range, designed to complement existing breast screening methods and provide additional insights to rule out breast cancer. Founded in 2010 and headquartered in Sydney, BCAL is listed on the Australian Securities Exchange.

Average Trading Volume: 184,141

Technical Sentiment Signal: Sell

Current Market Cap: A$24.52M

See more insights into BDX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1